The 16 secret retractions of Xuetao Cao at JBC
Chairman Cao’s 16 Retractions They Don’t Want You to Know About
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Chairman Cao’s 16 Retractions They Don’t Want You to Know About
“The 63 papers of Academician Cao Xuetao were questioned on the Internet. After investigation, no fraud, plagiarism and plagiarism were found, but many papers were found to have misuse of pictures, reflecting the lack of a strict laboratory management.”
Star scientists Michel and Andre Nussenzweig come from a famous family of immunologists. Clare Francis looked at some of their papers.
A review of “The Baltimore Case” by the historian Daniel Kelves and “Science Fictions” by the journalist John Crewdson, which also tell the history of the Office of Research Integrity (ORI).
Beware of Chinese collaborators bearing gift authorships!
As a young Wunderkind, Josef Penninger discovered the ACE2 receptor. Now he invented the cure for the coronavirus which will work in his hands where Big Pharma failed. He was never found guilty of research misconduct and never retracted a paper. Dr Penninger is a Genius making a COVID-19 vaccine.
University of Zurich and its Unispital has so much trouble with their medical professors right now. I wish to help.
Euroimmun founder Winfried Stöcker replies to criticism of his company’s publications: “Dr. Elisabeth Bik’s observations are not suitable to bring us into disrepute.”
EuroImmun is a German diagnostics biotech, founded by the most charming Professor Stöcker and recently sold to PerkinElmer. Elisabeth Bik checked some of company’s papers, many coauthored by Stöcker himself, and she raised questions. The company says this “testifies to a lack of knowledge of the matter”.
The prion researcher Adriano Aguzzi used to describe his Pubpeer critics as “lowlifes”, and himself as a victim of a lynch mob. But after Elisabeth Bik helped him find even more mistakes in his papers, Aguzzi changed his stance.
Have a WordPress.com account? Log in now.









